290 related articles for article (PubMed ID: 1551072)
1. Karyotypes in 90 human gliomas.
Thiel G; Losanowa T; Kintzel D; Nisch G; Martin H; Vorpahl K; Witkowski R
Cancer Genet Cytogenet; 1992 Feb; 58(2):109-20. PubMed ID: 1551072
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal composition of a series of 22 human low-grade gliomas.
Rey JA; Bello MJ; de Campos JM; Kusak ME; Moreno S
Cancer Genet Cytogenet; 1987 Dec; 29(2):223-37. PubMed ID: 3677044
[TBL] [Abstract][Full Text] [Related]
3. A cytogenetic study of 53 human gliomas.
Jenkins RB; Kimmel DW; Moertel CA; Schultz CG; Scheithauer BW; Kelly PJ; Dewald GW
Cancer Genet Cytogenet; 1989 Jun; 39(2):253-79. PubMed ID: 2752377
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas.
Ransom DT; Ritland SR; Kimmel DW; Moertel CA; Dahl RJ; Scheithauer BW; Kelly PJ; Jenkins RB
Genes Chromosomes Cancer; 1992 Nov; 5(4):348-56. PubMed ID: 1283324
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of chromosomal changes in human glioma progression. A cytogenetic study of 50 cases.
Debiec-Rychter M; Alwasiak J; Liberski PP; Nedoszytko B; Babińska M; Mrózek K; Imieliński B; Borowska-Lehman J; Limon J
Cancer Genet Cytogenet; 1995 Nov; 85(1):61-7. PubMed ID: 8536240
[TBL] [Abstract][Full Text] [Related]
6. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
7. Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas.
Rosso SM; van Dekken H; Krishnadath KK; Alers JC; Kros JM
J Neuropathol Exp Neurol; 1997 Oct; 56(10):1125-31. PubMed ID: 9329456
[TBL] [Abstract][Full Text] [Related]
8. Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors.
Arnoldus EP; Wolters LB; Voormolen JH; van Duinen SG; Raap AK; van der Ploeg M; Peters AC
J Neurosurg; 1992 Jun; 76(6):997-1003. PubMed ID: 1588436
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR
Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal characteristics of childhood brain tumors.
Bigner SH; McLendon RE; Fuchs H; McKeever PE; Friedman HS
Cancer Genet Cytogenet; 1997 Sep; 97(2):125-34. PubMed ID: 9283596
[TBL] [Abstract][Full Text] [Related]
11. Chromosome abnormalities in low-grade central nervous system tumors.
Griffin CA; Long PP; Carson BS; Brem H
Cancer Genet Cytogenet; 1992 May; 60(1):67-73. PubMed ID: 1591709
[TBL] [Abstract][Full Text] [Related]
12. DNA content and chromosomal composition of malignant human gliomas.
Bigner SH; Bjerkvig R; Laerum OD
Neurol Clin; 1985 Nov; 3(4):769-84. PubMed ID: 3001489
[TBL] [Abstract][Full Text] [Related]
13. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas.
Ransom DT; Ritland SR; Moertel CA; Dahl RJ; O'Fallon JR; Scheithauer BW; Kimmel DW; Kelly PJ; Olopade OI; Diaz MO
Genes Chromosomes Cancer; 1992 Nov; 5(4):357-74. PubMed ID: 1283325
[TBL] [Abstract][Full Text] [Related]
14. Are juvenile pilocytic astrocytomas benign tumors? A cytogenetic study in 24 cases.
Zattara-Cannoni H; Gambarelli D; Lena G; Dufour H; Choux M; Grisoli F; Vagner-Capodano AM
Cancer Genet Cytogenet; 1998 Jul; 104(2):157-60. PubMed ID: 9666811
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the NF2 gene in oligodendrogliomas and ependymomas.
Alonso ME; Bello MJ; Arjona D; Gonzalez-Gomez P; Lomas J; de Campos JM; Kusak ME; Isla A; Rey JA
Cancer Genet Cytogenet; 2002 Apr; 134(1):1-5. PubMed ID: 11996787
[TBL] [Abstract][Full Text] [Related]
16. Chromosome number and carmustine sensitivity in human gliomas.
Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic evidence for subtypes of oligoastrocytomas.
Maintz D; Fiedler K; Koopmann J; Rollbrocker B; Nechev S; Lenartz D; Stangl AP; Louis DN; Schramm J; Wiestler OD; von Deimling A
J Neuropathol Exp Neurol; 1997 Oct; 56(10):1098-104. PubMed ID: 9329453
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic analysis of gemistocytic cells in gliomas.
Kros JM; Waarsenburg N; Hayes DP; Hop WC; van Dekken H
J Neuropathol Exp Neurol; 2000 Aug; 59(8):679-86. PubMed ID: 10952058
[TBL] [Abstract][Full Text] [Related]
19. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses.
Schröck E; Thiel G; Lozanova T; du Manoir S; Meffert MC; Jauch A; Speicher MR; Nürnberg P; Vogel S; Jänisch W
Am J Pathol; 1994 Jun; 144(6):1203-18. PubMed ID: 8203461
[TBL] [Abstract][Full Text] [Related]
20. Amplification of the epidermal growth factor receptor gene in human gliomas.
Torp SH; Helseth E; Ryan L; Stølan S; Dalen A; Unsgaard G
Anticancer Res; 1991; 11(6):2095-8. PubMed ID: 1776845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
